PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Global PK/PD & Pharmacometrics, Eli Lilly and Company, Indianapolis, Indiana, USA.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1002/cpt.2420
?:doi
?:hasPublicationType
?:journal
  • Clinical pharmacology and therapeutics
is ?:pmid of
?:pmid
?:pmid
  • 34514598
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.699
?:rankingScore_hIndex
  • 169
is ?:relation_isRelatedTo_publication of
?:title
  • Population Pharmacokinetics and Pharmacodynamics of the Neutralizing Antibodies Bamlanivimab and Etesevimab in Patients With Mild to Moderate COVID-19 Infection.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all